The Latest Breaking News from FDA

Cannabis will likely soon be legally classified as medicine. But medicine for what?

Experts say the DEA’s rescheduling of cannabis as a medication will be ‘a little bit incoherent’

The Guardian - US · Jul 3, 2024

What is the US Supreme Court and how does it work? Joe Biden says Trump immunity is 'dangerous' for America

The justices find that a president has immunity for ‘official acts’ but is not immune for ‘unofficial acts’ — and refer the matter back to a trial judge

Evening Standard · Jul 3, 2024

What Is Kisunla? Know All About New FDA-Approved Drug For Alzheimer's Disease

Kisunla manufactured by Eli Lilly could significantly slow cognitive decline in people with early symptomatic Alzheimer's disease, according to results of the company's clinical trials.

Medical Daily · Jul 3, 2024

FDA approves second Alzheimer’s drug that can slow onset of disease

Eli Lilly says Kisunla demonstrated ‘meaningful results’ for people showing early symptoms of the disease

The Guardian - US · Jul 2, 2024

FDA approves a second Alzheimer's drug that can modestly slow disease

U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease

The Independent UK · Jul 2, 2024

3 Mid-Cap Stocks Analysts Believe Will Soar 50% or More

The blend of growth potential and stability in mid-cap pharma stocks is driven by rising demand for innovative therapies, strong economic conditions, and technological advancements that boost the sector's growth trajectory. Therefore, considering strong mid-cap stocks like Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and ACADIA Pharmaceuticals (ACAD), expected to soar…

StockNews.com · Jul 2, 2024

Fight over flavored vapes lands at Supreme Court - Roll Call

 The decision comes weeks after the FDA authorized the marketing of the first menthol-flavored vaping products.

Roll Call · Jul 2, 2024

Supreme Court to decide cases over online porn access, vapes - Roll Call

The Supreme Court announced Tuesday it will decide disputes over online access to pornography in Texas and FDA approval of vapes.

Roll Call · Jul 2, 2024

Is Organogenesis a Hidden Gem in the Biotech Sector?

Given Organogenesis’s (ORGO) upbeat first-quarter results and promising development of its ReNu program for knee osteoarthritis, the company seems to be on the brink of significant growth. Let’s delve into its fundamentals to determine whether it's a hidden gem in the biotech sector. Read more to find out….

StockNews.com · Jul 1, 2024

SCOTUS abortion 2024: while the issue may have had a good run, it may also set the stage for more restrictions

Two years after overturning Roe v. Wade, the Supreme Court takes on abortion once again. But its decisions may bring more restrictions in the long run

Latin Times · Jun 30, 2024